These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2411489)

  • 21. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism.
    Okumura K; Kita T; Chikazawa S; Komada F; Iwakawa S; Tanigawara Y
    Clin Pharmacol Ther; 1997 May; 61(5):509-17. PubMed ID: 9164413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlorpromazine and ethanol intoxication: an underlying mechanism.
    Messiha FS
    Neurobehav Toxicol Teratol; 1985; 7(2):185-8. PubMed ID: 3889687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of procainamide hydrochloride in dogs.
    Papich MG; Davis LE; Davis CA; McKiernan BC; Brown SA
    Am J Vet Res; 1986 Nov; 47(11):2351-8. PubMed ID: 2431636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary evaluation of the anti-arrhythmia effect of 4-acylamino-N[2-diethylaminoethyl]benzamides (N-acyl derivatives of procainamide)].
    Kusowska J; Sienkiewicz J
    Acta Pol Pharm; 1985; 42(4):367-73. PubMed ID: 2422880
    [No Abstract]   [Full Text] [Related]  

  • 25. Glutathione conjugation of perchloroethylene in rats and mice in vitro: sex-, species-, and tissue-dependent differences.
    Lash LH; Qian W; Putt DA; Desai K; Elfarra AA; Sicuri AR; Parker JC
    Toxicol Appl Pharmacol; 1998 May; 150(1):49-57. PubMed ID: 9630452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone modulation of N-acetylation in mouse kidney.
    Smolen TN; Brewer JA; Weber WW
    J Pharmacol Exp Ther; 1993 Feb; 264(2):854-8. PubMed ID: 8437129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of hepatic monooxygenases by phenobarbital, 3-methylcholanthrene, and polychlorinated biphenyls in rapid and slow acetylator mice.
    Elves RG; Ueng TH; Alvares AP
    Drug Metab Dispos; 1985; 13(3):354-8. PubMed ID: 2861996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the metabolism of oltipraz in the mouse, rat and monkey and in man. Distribution of the metabolites in each species.
    Bieder A; Decouvelaere B; Gaillard C; Depaire H; Heusse D; Ledoux C; Lemar M; Le Roy JP; Raynaud L; Snozzi C
    Arzneimittelforschung; 1983; 33(9):1289-97. PubMed ID: 6685510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species- and sex-related differences in metabolism of trichloroethylene to yield chloral and trichloroethanol in mouse, rat, and human liver microsomes.
    Elfarra AA; Krause RJ; Last AR; Lash LH; Parker JC
    Drug Metab Dispos; 1998 Aug; 26(8):779-85. PubMed ID: 9698293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Aug; 234(2):358-64. PubMed ID: 3874952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the determination of the acetylation phenotype during treatment with procainamide].
    Aubry JP; Biour M; Cheymol A; Jaillon P
    Therapie; 1980; 35(5):653-4. PubMed ID: 6163220
    [No Abstract]   [Full Text] [Related]  

  • 34. Interindividual variability in 5-Fluorouracil metabolism and procainamide N-acetylation in human liver cytosol.
    Niwa T; Shiraga T; Ohno Y; Kagayama A
    Biol Pharm Bull; 2005 Jun; 28(6):1071-4. PubMed ID: 15930747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of procainamide and p-aminobenzoic acid in patients with chronic liver disease.
    du Souich P; Erill S
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):588-95. PubMed ID: 303166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic constancy, respectively subline drifting of inbred strains of rats and mice].
    Hedrich HJ; Rapp KG; Zschege C
    Z Versuchstierkd; 1975; 17(5-6):263-74. PubMed ID: 1210818
    [No Abstract]   [Full Text] [Related]  

  • 37. Electrochemical determination of N-oxidized procainamide metabolites and functional assessment of effects on murine cells in vitro.
    Wheeler JF; Lunte CE; Heineman WR; Adams L; Hess EV
    Proc Soc Exp Biol Med; 1988 Jul; 188(3):381-6. PubMed ID: 2455906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease and acetylation polymorphism.
    Lunde PK; Frislid K; Hansteen V
    Clin Pharmacokinet; 1977; 2(3):182-97. PubMed ID: 328206
    [No Abstract]   [Full Text] [Related]  

  • 39. Sex differences and androgenic regulation of esterases in the house mouse.
    Tegelström H; Ryttman H
    Hereditas; 1981; 94(2):189-201. PubMed ID: 7298352
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-related lupus. Incidence, mechanisms and clinical implications.
    Adams LE; Hess EV
    Drug Saf; 1991; 6(6):431-49. PubMed ID: 1793523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.